ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 286

Imaging Neoangiogenesis in Rheumatoid Arthritis (INIRA): Whole-Body Synovial Uptake of a 99mTc-Labelled RGD Peptide Is Highly Correlated with Power Doppler Ultrasound

Laura Attipoe1, Toby Garrood 2, Sujith Subesinghe 2, Maria Opena 2, Cristina Blanco-Gil 2, Mark Rosser 3, Gary Cook 4 and Andrew Cope 5, 1Rheumatology Dept, King's College London, London, United Kingdom, 2Rheumatology Dept, Guy's and St Thomas' Hospitals NHS Trust, London, United Kingdom, 3Serac Life Sciences, Thames Ditton, England, United Kingdom, 4Nuclear Medicine Dept, Guy's and St Thomas' Hospitals NHS Trust, London, United Kingdom, 5Academic Rheumatology, King's College London, London, United Kingdom

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: rheumatoid arthritis (RA) and Imaging, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 10, 2019

Title: Imaging Of Rheumatic Diseases Poster I

Session Type: Poster Session (Sunday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Power doppler ultrasound (PDUS) is superior to clinical examination in the detection of synovitis in patients with rheumatoid arthritis (RA). Although dynamic and cheap it is impractical to scan large numbers of joints in routine clinical settings. MRI, whilst sensitive for synovitis, is expensive, and routine use is limited to targeted joints. Bone scintigraphy produces whole body images but due to lower specificity is not routinely used to detect synovitis

99mTc-maraciclatide (Serac Healthcare) is a radio-labelled tracer which binds with high affinity to integrin αvβ3, a cell-adhesion molecule up-regulated on neoangiogenic blood vessels. It therefore has the potential to image synovial inflammation at the whole-body level. We previously showed in a pilot study that uptake was seen in the inflamed joints of 5 RA patients and that this correlated with PDUS1. This study explores correlation with PDUS in a larger groups of patients with a range of disease activities

Methods: 25 patients with RA, fulfilling ACR 2010 classification criteria, were recruited. Patients underwent 66/68 swollen/tender joint counts followed by an ultrasound scan of 38 joints with grey scale (GS) and PD quantification. As per OMERACT guidelines, each joint was scored on a scale of 0-3 for GS and PD with a total score calculated for each patient. Within 3 hours of the ultrasound, patients were injected with 740 MBq of 99mTc-maraciclatide. Using a gamma camera, whole body planar views and dedicated hand and foot views were taken 2 hours after injection. Acquisition time was 20 minutes for whole body, and 20 minutes for hand and foot views.   Nuclear medicine images were scored as positive or negative uptake for each joint (binary score). Binary scores were summed individually to derive a total score for each patient. Ultrasound and 99mTc-maraciclatide scores were tested for correlation with Pearson’s correlation coefficient. Significance was set at p< 0.05

Results: Strong correlation was seen between total PDUS and binary scores (r=0.93, r2=0.86, p< 0.001). In the wrists and ankles 99mTc-maraciclatide uptake was seen not only in synovitic joints but in inflamed tendons/ tendon sheaths. The imaging procedure was well-tolerated

Conclusion: 99mTc-maraciclatide uptake was highly correlated with PDUS highlighting its potential as a viable alternative imaging modality. 99mTc-based planar imaging has the unique capacity to image the whole body and hence the total synovial inflammatory load in a quick acquisition. Furthermore the imaging equipment to perform these scans is already widely available in nuclear imaging departments. Interpretation of scans is also much simpler compared to US and MRI. It could therefore have a role in key decision-making points in pathways for diagnosis, treatment failure, and remission prior to dose tapering.  Recruitment is underway to expand the data to a larger group of patients

Reference:
1. Garrood T, Morrison M, Shivapatham D, Chaabo K, Ul-Hassan F, Ballinger J, Cook G, Cope AP. Whole-Body Synovial Uptake of a 99mtc-Labelled RGD Peptide Is Highly Correlated with Power Doppler Ultrasound [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10)


figure 1 pd vs binary acr 2019

Figure 1: Correlation between total power doppler and 99mTc-maraciclatide binary scores


figure 2 hand and foot images acr 2019

Figure 2: 99mTc-maraciclatide imaging with dedicated hand and foot views


figure 3 whole body image acr 2019

Figure 3: 99mTc-maraciclatide whole body image


Disclosure: L. Attipoe, None; T. Garrood, None; S. Subesinghe, None; M. Opena, None; C. Blanco-Gil, None; M. Rosser, Serac Life Sciences, 4, Serac Life Sciences, 4; G. Cook, Guy's and st Thomas' Hospitals NHS Trust, 2; A. Cope, None.

To cite this abstract in AMA style:

Attipoe L, Garrood T, Subesinghe S, Opena M, Blanco-Gil C, Rosser M, Cook G, Cope A. Imaging Neoangiogenesis in Rheumatoid Arthritis (INIRA): Whole-Body Synovial Uptake of a 99mTc-Labelled RGD Peptide Is Highly Correlated with Power Doppler Ultrasound [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/imaging-neoangiogenesis-in-rheumatoid-arthritis-inira-whole-body-synovial-uptake-of-a-99mtc-labelled-rgd-peptide-is-highly-correlated-with-power-doppler-ultrasound/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/imaging-neoangiogenesis-in-rheumatoid-arthritis-inira-whole-body-synovial-uptake-of-a-99mtc-labelled-rgd-peptide-is-highly-correlated-with-power-doppler-ultrasound/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology